Valuation: Sartorius AG

Market Cap 16.41B 18.7B 15.49B 14.12B 26.43B 1,792B 26.62B 185B 71.82B 915B 70.2B 68.68B 2,942B P/E 2026 *
70x
P/E 2027 * 53.8x
Enterprise Value 19.98B 22.77B 18.87B 17.2B 32.19B 2,182B 32.42B 226B 87.46B 1,115B 85.49B 83.64B 3,583B EV / Sales 2026 *
5.37x
EV / Sales 2027 * 4.82x
Free-Float
35.87%
Yield 2026 *
0.3%
Yield 2027 * 0.37%
1 day+1.69%
1 week+7.16%
Current month+2.10%
1 month+2.10%
3 months+13.18%
6 months+11.09%
Current year+2.68%
1 week 275.96
Extreme 275.9595
275.96
1 month 257.53
Extreme 257.53
275.96
Current year 233.92
Extreme 233.92
312.93
1 year 226.38
Extreme 226.375
312.93
3 years 198.85
Extreme 198.8499
423.7
5 years 198.85
Extreme 198.8499
736.22
10 years 74.75
Extreme 74.75
736.22
Manager TitleAgeSince
Chief Executive Officer 59 29/06/2025
Director of Finance/CFO 55 31/03/2024
Chief Operating Officer 70 31/12/2000
Director TitleAgeSince
Director/Board Member 62 31/08/2002
Chairman 69 18/07/2017
Director/Board Member 77 28/11/2011
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%+7.16% - - 18.65B
-2.64%+4.45%+31.82%-18.21% 18.65B
-5.20%-1.26%-40.28%+23.38% 1.85B
0.00%+0.41%-30.18%+23.60% 866M
+0.03%-0.05%+54.52%-2.58% 778M
+0.84%+2.35%-59.04%-84.81% 733M
-0.69%+8.32%-30.46%-46.60% 686M
+1.77%+5.45%-38.77%-51.24% 589M
+0.04%+10.54%+41.61%+92.40% 476M
+5.05%+7.11%-0.46%+9.25% 399M
Average +0.25%+2.21%-7.92%-6.09% 2.78B
Weighted average by Cap. -0.41%+5.29%+18.70%-14.17%

Financials

2026 *2027 *
Net sales 3.72B 4.24B 3.52B 3.2B 6B 407B 6.04B 42.08B 16.3B 208B 15.93B 15.59B 668B 4.08B 4.65B 3.86B 3.51B 6.58B 446B 6.63B 46.15B 17.87B 228B 17.47B 17.09B 732B
Net income 255M 291M 241M 220M 411M 27.89B 414M 2.89B 1.12B 14.25B 1.09B 1.07B 45.8B 329M 374M 310M 283M 529M 35.89B 533M 3.71B 1.44B 18.34B 1.41B 1.38B 58.93B
Net Debt 3.58B 4.07B 3.38B 3.08B 5.76B 390B 5.8B 40.4B 15.65B 199B 15.3B 14.97B 641B 3.27B 3.73B 3.09B 2.81B 5.27B 357B 5.31B 36.95B 14.31B 182B 13.99B 13.69B 586B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,279
Date Price Change Volume
21/09/26 US$275.96 +1.69% 85
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
265.30EUR
Average target price
271.74EUR
Spread / Average Target
+2.43%

Quarterly revenue - Rate of surprise